CLOSTRIDIUM DIFFICILE INFECTION
Clinical trials for CLOSTRIDIUM DIFFICILE INFECTION explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIUM DIFFICILE INFECTION trials appear
Sign up with your email to follow new studies for CLOSTRIDIUM DIFFICILE INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dietary change may cut c. diff recurrence in cancer patients
Disease control CompletedThis study looked at whether eating less fat and more fiber can lower the chance of a repeat Clostridioides difficile infection in people being treated for cancer. Eight patients with leukemia, lymphoma, or other cancers who had a recent C. diff infection took part. Researchers t…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 17, 2026 11:48 UTC
-
Poop pills? fecal transplant shows promise for gut infection
Disease control CompletedThis study tested a procedure called fecal microbiota transplant (FMT) in 24 adults with recurring Clostridium difficile (C. diff) infection. FMT involves placing healthy donor stool into the patient's colon to restore good bacteria killed by antibiotics. The goal was to see if F…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION
Phase: PHASE4 • Sponsor: Methodist Health System • Aim: Disease control
Last updated May 17, 2026 11:37 UTC
-
Poop pills plus antibody: a new hope for stubborn gut infections?
Disease control CompletedThis study tested whether adding a drug called bezlotoxumab to a fecal transplant (FMT) could better prevent repeat C. diff infections in people with inflammatory bowel disease (IBD). About 61 adults with both IBD and recurrent C. diff were randomly assigned to get FMT plus bezlo…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
Simple taper strategy may cut c. diff recurrence risk
Prevention CompletedThis study looked at whether giving a gradual, lower dose of vancomycin for two extra weeks after the standard treatment can prevent C. diff infection from coming back. About 263 adults who had their first or second C. diff infection took part. Half received a placebo and half re…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION
Phase: PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated May 17, 2026 11:35 UTC
-
Should cancer patients get antibiotics for a weak c. diff test? study investigates.
Knowledge-focused CompletedThis study looked at cancer patients with diarrhea who tested positive for C. diff bacteria but negative for the toxin that usually causes illness. Half received an antibiotic (vancomycin) and half received a placebo for 14 days. The goal was to see how the treatment affected bac…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC